Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Global Cancer Diagnostics Platform Announced
Big Pharma is racing to find a cure for all types of cancer. Now there’s a $2.8 billion deal that unites two cancer diagnostics companies. Exact Sciences Corporation (NYSE: EXAS), a molecular diagnostics company and maker of the Cologuard colorectal screening test, announced its acquisition of Genomic Health, Inc. (NASDAQ: GHDX) in late July. Genomic Health provides genomic-based diagnostic tests that improve cancer care, including addressing the overtreatment of the disease. Its lead product, Oncotype DX, manages clinical and genomic big data to support research and treatment for over 1 million cancer patients. The combined company will offer two of the strongest brands in cancer... Read More »
Behavioral Health Care Sector Recovers in Q2:19
After a slump in the first quarter of 2019, the Behavioral Health Care sector rebounded in the second quarter. Twenty-three deals were announced in the second quarter of 2019, a 64% increase over the 14 deals in the first quarter, and a slight 10% increase compared with the same quarter last year. And much like the previous quarter and Q2:18, none of the deals disclosed financial terms. However, if prices had been disclosed, the largest would likely have been Anthem Inc.’s (NYSE: ANTM) acquisition of Beacon Health Options from Bain Capital Private Equity and Diamond Castle Holdings. Beacon offers clinical mental health and substance use disorder management, a comprehensive employee... Read More »
Q2:19 Healthcare Deal Value, Services vs. Technology
Healthcare deal value in the second quarter totaled $138.7 billion, a slight 7% decrease from the first quarter’s $149.0 billion. Both quarters in 2019 featured a single, mega-billion-dollar deal—the $74 billion Bristol-Myers Squibb/Celgene deal in Q1 and the $87 billion AbbVie/Allergan hook-up in Q2—while the second quarter of 2018 included Takeda’s $81.5 billion deal for Shire plc. The graph below seems to indicate something terribly wrong happened in the second half of 2018, but the spending totals of those two quarters are more typical than the $100-billion-plus quarters that began in Q4:17. Economic uncertainty is still very present in mid-2019 and could grow into a recession at some... Read More »
Q2:19 Healthcare Deal Volume, Services vs. Technology Sectors
With 431 deals announced in the second quarter, acquisition activity was 9% higher than the 394 transactions announced in the previous quarter. Year over year, however, deal volume was 11% lower than the same quarter in 2018, which had 484 deals. The first quarter of 2019 was the slowest of the previous four quarters, at 394 deals. Happily, the second quarter’s activity picked up, as many deal makers predicted it would. Still, talk of recession has grown more insistent, with deal makers predicting an economic slowdown within 12 months to two years. The urgency to complete deals in 2019 has likely fueled some of the activity we’re seeing this year. Deal volume in the health care services... Read More »
Health Care M&A Deals, Week Ending July 26, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Ligand Pharmaceuticals Incorporated Ab Initio Biotherapeutics $12,000,000 Zambon S.p.A. Breath Therapeutics GmbH $156,190,000 eHealth Acquirer Target Price BioTelemetry, Inc. ADEA Medical AB N/A Hospitals Acquirer Target Price Medical... Read More »
Health Care M&A Deals, Week Ending July 19, 2019
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Boehringer Ingelheim AMAL Therapeutics N/A AbbVie Inc. Mavupharma N/A Interpace Diagnostics Group, Inc. Biopharma services business $23,500,000 LifeSpan BioSciences Everest Biotech Ltd. N/A Astellas Pharma Inc. Exclusive license to FX-322 $80,000,000 Gilead... Read More »
Outpatient Rehab Platform Adds On
Another rehabilitation platform made an add-on acquisition. Lima, Ohio-based CORA Health Services, a portfolio company of Gryphon Investors, announced its acquisition of Orthopedic and Sports Therapy Institute (OSTI) in Rockford, Illinois. CORA has more than 100 clinics in Florida, Georgia, Michigan, North and South Carolina, Tennessee and Virginia. OSTI offers a wide variety of services, including general physical therapy and specialty programs in balance and fall prevention, golf therapy, oncology rehabilitation, pain management and more. Its clinics are located in Rockford, Belvidere, Marengo, Ogle County, Poplar Grove and Sauk Valley. Gryphon acquired CORA in June 2016. It made its... Read More »
Agilent Acquires BioTek Instruments
Agilent Technologies (NYSE: A) announced its largest deal ever in July 2019. The Santa Clara, California-based biotech purchased privately held BioTek Instruments for nearly $1.2 billion. Agilent provides bio-analytical solutions and services to the life sciences, diagnostics, and genomics, chemical analysis, communications and electronics industries worldwide. On a trailing 12-month basis it generated revenue of $5.0 billion, EBITDA of $1.2 billion and net income of $1.1 billion. BioTek designs, manufactures and distributes life science instrumentation worldwide. Its product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators and stackers.... Read More »
U.S. Hospital REIT Deals Roar Back in 2019
REIT deals are back in the Hospital sector, after a two-year lull. Through mid-July, six transactions targeting U.S. hospitals were announced by real estate investment trusts (REITs), a total that equals the annual REIT deal volume of 2013, 2015 and 2016. Three of this year’s U.S. deals were announced in July 2019. Medical Properties Trust (NYSE: MPW) made a splash, announcing a combined $1.75 billion invesment in 24 hospital facilities through three separate transactions. The largest of the three, at $1.55 billion, was for 14 acute care hospitals and two behavioral health hospitals (2,383 beds) owned by for-profit Prospect Medical Holdings in California, Connecticut and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
